MetaADEDB 2.0 @ LMMD
eribulin
(UFNVPOGXISZXJD-JBQZKEIOSA-N)
Structure
SMILES
NC[C@H](C[C@H]1O[C@@H]2[C@@H]([C@H]1OC)CC(=O)C[C@H]1CC[C@H]3[C@H](O1)[C@@H]1O[C@]4(CC[C@@H]5O[C@@H](CC[C@@H]6O[C@H](C2)C(=C)[C@@H](C6)C)C(=C)C5)O[C@@H]2[C@H](O3)[C@H]1O[C@@H]2C4)O
Type(s)
Approved; Investigational
ATC code(s)
L01XX41
Molecular Formula:
C40H59NO11
Molecular Weight:
729.897
Log P:
4.1383
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
2
TPSA:
146.39
CAS Number(s):
253128-41-5
Synonym(s)
1.
eribulin
2.
B 1793
3.
B 1939
4.
B-1793
5.
B-1939
6.
E 7389
7.
E-7389
8.
ER 086526
9.
ER-086526
10.
ER-86526
11.
ER086526
12.
Halaven
13.
NSC 707389
14.
NSC-707389
15.
NSC707389
16.
eribulin (as mesylate)
17.
eribulin mesilate
18.
eribulin mesylate
19.
eribulin monomethanesulfonate
External Link(s)
MeSHC490954
PubChem Compound11354606
ChEBI63587
CHEMBLCHEMBL1683590
DrugBankDB08871
DrugCentral4171
IUPHAR/BPS Guide to PHARMACOLOGY6813
ZINC169344691
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NeutropeniaFAERS: 25SIDER
US FAERS
2Febrile NeutropeniaFAERS: 18SIDER
US FAERS
3Malignant neoplasm progressionFAERS: 10US FAERS
4Pulmonary EmbolismFAERS: 6SIDER
US FAERS
5ThrombocytopeniaFAERS: 6SIDER
US FAERS
6FatigueFAERS: 5SIDER
US FAERS
7DizzinessFAERS: 4SIDER
US FAERS
8Neutrophil count decreasedFAERS: 4US FAERS
9StomatitisFAERS: 4SIDER
US FAERS
10AgranulocytosisFAERS: 3US FAERS
11AstheniaFAERS: 3SIDER
US FAERS
12Bone painFAERS: 3SIDER
US FAERS
13CystitisFAERS: 3US FAERS
14EmbolismFAERS: 3US FAERS
15HydronephrosisFAERS: 3US FAERS
16LeukopeniaFAERS: 3SIDER
US FAERS
17PneumoniaFAERS: 3SIDER
US FAERS
18VomitingFAERS: 3SIDER
US FAERS
19Abdominal PainFAERS: 2SIDER
US FAERS
20Acute kidney injuryFAERS: 2US FAERS
21Capillary Leak SyndromeFAERS: 2US FAERS
22Cerebrovascular accidentFAERS: 2US FAERS
23ConstipationFAERS: 2SIDER
US FAERS
24DehydrationFAERS: 2SIDER
US FAERS
25Disease ProgressionFAERS: 2US FAERS
26DysuriaFAERS: 2SIDER
US FAERS
27Gastrointestinal PainFAERS: 2SIDER
US FAERS
28General physical health deteriorationFAERS: 2US FAERS
29HeadacheFAERS: 2SIDER
US FAERS
30HypertransaminasaemiaFAERS: 2US FAERS
31Infusion Site ExtravasationFAERS: 2US FAERS
32Lower respiratory tract infectionFAERS: 2US FAERS
33Oral candidiasisFAERS: 2SIDER
US FAERS
34PancytopeniaFAERS: 2SIDER
US FAERS
35Pelvic PainFAERS: 2US FAERS
36Pericardial effusionFAERS: 2US FAERS
37Radiation proctitisFAERS: 2US FAERS
38SepsisFAERS: 2SIDER
US FAERS
39SyncopeFAERS: 2US FAERS
40TachycardiaFAERS: 2SIDER
US FAERS
41Urinary tract infectionFAERS: 2SIDER
US FAERS
42White blood cell count decreasedFAERS: 2US FAERS
43AgitationFAERS: 1US FAERS
44Alanine Aminotransferase IncreasedFAERS: 1SIDER
US FAERS
45AlopeciaFAERS: 1SIDER
US FAERS
46AngioedemaFAERS: 1SIDER
US FAERS
47ArthralgiaFAERS: 1SIDER
US FAERS
48Back PainFAERS: 1SIDER
US FAERS
49Blood creatinine increasedFAERS: 1US FAERS
50CellulitisFAERS: 1US FAERS
51Cerebral InfarctionFAERS: 1US FAERS
52Chest discomfortFAERS: 1US FAERS
53Corynebacterium test positiveFAERS: 1US FAERS
54Culture urine positiveFAERS: 1US FAERS
55Deafness NeurosensoryFAERS: 1US FAERS
56Deep Vein ThrombosisFAERS: 1SIDER
US FAERS
57Device related infectionFAERS: 1US FAERS
58Diabetes mellitus inadequate controlFAERS: 1US FAERS
59DisorientationFAERS: 1US FAERS
60DysgeusiaFAERS: 1SIDER
US FAERS
61Escherichia test positiveFAERS: 1US FAERS
62Failure to ThriveFAERS: 1US FAERS
63Feeling ColdFAERS: 1US FAERS
64Feeling abnormalFAERS: 1US FAERS
65Flank PainFAERS: 1US FAERS
66GastritisFAERS: 1US FAERS
67Hepatic EncephalopathyFAERS: 1US FAERS
68HyperpyrexiaFAERS: 1US FAERS
69HypotensionFAERS: 1US FAERS
70HypoxiaFAERS: 1US FAERS
71Incision site complicationFAERS: 1US FAERS
72IncoherentFAERS: 1US FAERS
73InfectionFAERS: 1SIDER
US FAERS
74Intestinal ObstructionFAERS: 1US FAERS
75LaryngitisFAERS: 1US FAERS
76MalaiseFAERS: 1US FAERS
77Mental status changesFAERS: 1US FAERS
78MyalgiaFAERS: 1SIDER
US FAERS
79Myocardial InfarctionFAERS: 1US FAERS
80NauseaFAERS: 1SIDER
US FAERS
81Neck PainFAERS: 1US FAERS
82NecrosisFAERS: 1US FAERS
83NeuralgiaFAERS: 1US FAERS
84Neutropenic sepsisFAERS: 1SIDER
US FAERS
85Oral fungal infectionFAERS: 1US FAERS
86PainFAERS: 1SIDER
US FAERS
87Pathological fractureFAERS: 1US FAERS
88Pelvic massFAERS: 1US FAERS
89Pelvic venous thrombosisFAERS: 1US FAERS
90PneumonitisFAERS: 1US FAERS
91PolyneuropathyFAERS: 1SIDER
US FAERS
92Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
93PresyncopeFAERS: 1US FAERS
94PseudomeningoceleFAERS: 1US FAERS
95PurulenceFAERS: 1US FAERS
96Septic ShockFAERS: 1US FAERS
97Skin toxicityFAERS: 1US FAERS
98Streptococcus test positiveFAERS: 1US FAERS
99SuperinfectionFAERS: 1US FAERS
100ThrombophlebitisFAERS: 1US FAERS
101ThrombosisFAERS: 1US FAERS
102Toxic Epidermal NecrolysisFAERS: 1US FAERS
103VertigoFAERS: 1SIDER
US FAERS
104pseudomembranous colitisFAERS: 1US FAERS
105AnorexiaSIDER
106Aspartate Aminotransferase IncreasedSIDER
107Blood and lymphatic system disordersSIDER
108Chest PainSIDER
109ChillsSIDER
110ConjunctivitisSIDER
111CytopeniaSIDER
112DermatitisSIDER
113Disseminated Intravascular CoagulationSIDER
114Dry skinSIDER
115DyspepsiaSIDER
116Ear and labyrinth disordersSIDER
117EpistaxisSIDER
118ErythemaSIDER
119Hepatic cancer metastaticSIDER
120HepatotoxicitySIDER
121InfestationSIDER
122LethargySIDER
123LymphopeniaSIDER
124MalnutritionSIDER
125Musculoskeletal PainSIDER
126Musculoskeletal chest painSIDER
127Musculoskeletal discomfortSIDER
128NasopharyngitisSIDER
129NeuritisSIDER
130Night sweatsSIDER
131Oropharyngeal painSIDER
132PancreatitisSIDER
133Peripheral motor neuropathySIDER
134Protein urine presentSIDER
135ProteinuriaSIDER
136PruritusSIDER
137RhinitisSIDER
138TinnitusSIDER
139Weight decreasedSIDER
140nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.